You are here

Article info

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Metformin is not significantly different from insulin for preventing fetal macrosomia in women with gestational diabetes

Authors

  1. Correspondence to Steve L Hyer
    Diabetes Centre, Epsom & St Helier University Hospitals NHS Trust, Wrythe Lane, Carshalton SM5 1AA, UK; steve.hyer{at}esth.nhs.uk
View Full Text

Citation

Hyer SL
Metformin is not significantly different from insulin for preventing fetal macrosomia in women with gestational diabetes
BMJ Evidence-Based Medicine 2012;17:88-89.

Publication history

  • First published September 21, 2011.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions